HINGHAM, Mass., Feb. 24, 2020 /PRNewswire/ -- Wellness Workdays, a leading provider of worksite wellness programs, announces the first speakers for the 7th Annual Emerging Trends in Wellness Conference on April 1-2. The event, which will be held at Granite Links outside of Boston, will feature lead

TORONTO, Feb. 24, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(

GERMANTOWN, Md., Feb. 24, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced it will release fourth quarter and full year 2019 financial results after the market closes on Monday, March 2

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate in four upcoming investor conferences. 

NEW YORK, Feb. 24, 2020 /PRNewswire/ -- AdvantageCare Physicians (ACPNY), one of New York's largest primary and specialty care practices and part of the EmblemHealth family of companies, today announced the opening of an innovative, employee-focused medical office at its 55 Water Street headquarters in New York C

ATLANTA, Feb. 24, 2020 /PRNewswire/ -- Antios Therapeutics, Inc. ("Antios"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application No. 15/536,237, titled, "Ph

ALPHARETTA, Ga., Feb. 24, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two investor conferences in March:

MINNEAPOLIS, Feb. 24, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Chief Financial Officer, will present at the Cowen 40th Annual Health Care Conference on Wednesday, March 4, 2020 at 8:00 a.m. EST. The conference

SALT LAKE CITY, Feb. 24, 2020 /PRNewswire/ -- Lipocine Inc. (LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the results of its Post Action meeting with the U.S. Food and Drug Administration ("FDA') regarding its New Drug Application ("NDA") for TLANDO™, the Company's oral testosterone product can

RESEARCH TRIANGLE PARK, N.C. and MANCHESTER, N.H., Feb. 24, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) and DEKA Research & Development Corp. today announced receipt of an additional 510(k) clearance by the U.S. Food and Drug Administration (FDA) related to the Unity Subcutaneous Delivery System for Remodulin